What Is Pharmacovigilance?
Experts at CSL describe this important safety system from a patient’s point of view.
CSL. Always Evolving for a Better World.
CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.
Our Businesses and Products
CSL. Always Evolving for a Better World.
CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.
Our Businesses and Products
CSL Behring. Leading the Way in Treating Rare and Serious Diseases.
CSL Behring is a global biotech leader with a broad range of biotherapies for rare and serious diseases including bleeding disorders, immunodeficiencies, hereditary angioedema, neurological disorders and Alpha 1 Antitrypsin Deficiency.
More About CSL Behring
CSL Plasma. Helping Those in Need Live Healthier Lives.
CSL Plasma operates one of the world’s largest and most sophisticated plasma collection networks, with more than 300 plasma collection centers in the U.S., Europe and China. The plasma collected is used by CSL Behring for the purpose of manufacturing and delivering its life-saving therapies to people in more than 100 countries.
More About CSL Plasma
CSL Seqirus. On the Front Line of Public Health Protection.
As the only vaccine company with a singular global focus on influenza, we work tirelessly on cutting-edge research, transformative technologies, and the latest methods of production and distribution. Together with our partners we’re on the front line every day, working to help protect communities from seasonal influenza and global pandemic threats.
More About CSL Seqirus
CSL Vifor. Changing the Game in Iron Deficiency and Nephrology.
The newest member of the CSL family, CSL Vifor is a global leader in iron deficiency and nephrology and is committed to launching the next generation of therapies to truly address the full spectrum of kidney disease, with a focus on dialysis and rare disease.
More About CSL ViforVita: Original Stories
'Vita' means life. It's also where we share the stories of biotech's promise to patients and public health.
Seeking Radical Progress for Lung Disease Patients
CSL Behring in Marburg, Germany, helped launch the Open Source Imaging Consortium to include data collection about Alpha 1 Antitrypsin Deficiency.
Explainer: Pulmonary Fibrosis
Pulmonary Fibrosis is a group of more than 200 diseases marked by scarring in the lungs.
New Data Looks at Plasma Donor Health
An article, published in the journal Transfusion, analyzed U.S. donors’ self-reported responses about their health.
Careers at CSL
We are committed to helping employees fulfill their career aspirations while working in a values-based culture. Are you next?
Members of our CSL Seqirus team attended the 9th European Scientific Working group on Influenza (ESWI) ’s Influenza Conference this week, where we had the opportunity to engage with some of the greatest minds in influenza and vaccine research and discover the latest advancements and innovations in the field. Click here to learn more about CSL and how we’re Driven by Our Promise: https://bit.ly/3td1kXq #CSLSeqirus #ESWI #Spain #Valencia #Influenza #DrivenByOurPromise
We wish our CSL team a weekend of smooth riding as they trek 100+ miles in support of patients who have respiratory conditions such as Alpha 1 Antitrypsin Deficiency. Phil Klara, an Associate Director in Marketing and a triathlete, explains how to prepare for a long-distance ride like Escape to the Cape. https://bit.ly/3PpsIch
SAVE THE DATE: CSL is proud to be sponsoring the symposium "Personalisation In Disease: diagnosing, managing and empowering patients with primary immunodeficiency” at IPIC 2023 (IPOPI - International Patient Organisation for Primary Immunodeficiencies ) in Rotterdam, the Netherlands. We look forward to welcoming you on Thursday 9 November at 07:30 AM CET! #IPIC2023 #PrimaryImmunodeficiencies #PatientCare
Today, we commemorate International Day of Peace. It's a reminder to foster peace and understanding, bridging gaps between nations and promoting harmony among diverse communities. #InternationalDayofPeace #WorldPeaceDay
Last week, across our Australian network of sites we proudly launched our inaugural Reconciliation Action Plan \(RAP\). Our formal commitment to advance our efforts to support reconciliation efforts with Aboriginal and Torres Strait Islanders – the world’s oldest continuous living culture. Our Reflect RAP is an integral first step in our formal reconciliation journey and efforts to maintain dialogue with Aboriginal and Torres Strait Islander peoples, and listen with understanding, compassion and respect to enable a future of strong partnerships and achievements. For us there is only moving forward – together. Learn more about our RAP here: https://bit.ly/3RuHIbv #reconciliationactionplan #reconciliation #australia
Drone Video: Watch for a birds-eye view of a delicate operation that delivered 66 tons of equipment through the roof of CSL Behring's facility in Bern, Switzerland. https://bit.ly/44Xl6Uk
Brandon Wilkinson was working in Brisbane, Australia when he was bitten on the hand by a venomous spotted black snake. After applying the pressure immobilisation technique, Brandon was able to quickly receive expert medical care at the nearest hospital. CSL is proud to partner with the Australian Government through CSL Seqirus to develop and deliver potentially lifesaving antivenoms, educate Australians about snakebite prevention and be a partner in the Papua New Guinea Snakebite Project. Learn more about how we’re helping address snakebite in Asia Pacific: https://bit.ly/3LuSniy #ISBAD23 #BitesAndStings #PublicHealth #CSLSeqirus
#MondayMotivation
“CSL was created with the intention of serving people, enabling them to live full lives and with a commitment to protect their health by providing safe and effective products, I am privileged and humbled to work for CSL, where patient safety is the highest priority," said Eric Teo, Senior Vice President, Global Head of Patient Safety & Pharmacovigilance. https://bit.ly/3sVmKZl
Today, we acknowledge World Patient Safety Day. It's a reminder to prioritize patient well-being, drive continuous improvement, and foster a culture of safety across healthcare organizations. #WorldPatientSafetyDay